SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-22-004248
Filing Date
2022-01-28
Accepted
2022-01-28 16:35:31
Documents
4
Period of Report
2022-01-28

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea154626-6k_mainzbio.htm 6-K 14325
2 UNDERWRITING AGREEMENT, DATED JANUARY 25, 2022, BETWEEN MAINZ BIOMED N.V. AND BO ea154626ex1-1_mainzbio.htm EX-1.1 223944
3 PRESS RELEASE, DATED JANUARY 25, 2022 ea154626ex99-1_mainzbio.htm EX-99.1 9258
4 PRESS RELEASE, DATED JANUARY 28, 2022 ea154626ex99-2_mainzbio.htm EX-99.2 11196
  Complete submission text file 0001213900-22-004248.txt   259784
Mailing Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129
Business Address ROBERT KOCH STRASSE 50 MAINZ 2M 55129 49 6131 5542860
MAINZ BIOMED N.V. (Filer) CIK: 0001874252 (see all company filings)

IRS No.: 000000000 | State of Incorp.: P7 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-41010 | Film No.: 22569396
SIC: 2834 Pharmaceutical Preparations